Is ZWS a Buy or a Sell? The Bull and Bear Case (2026)
Last updated October 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Zurn Elkay Water Solutions (ZWS) rests on Water-focused secular demand: ZWS is levered to long-run themes in water quality, safety, conservation, and hygiene across institutional and commercial buildings. The bear case rests on zWS trades at a premium price-to-earnings multiple (about 29x trailing and 23x forward as of October 2026), so any slowdown in growth or margin momentum could pressure the stock; consensus expects growth to slow to about 11% in 2027. Analysts covering it publish targets from $51.00 to $65.00 against a $47.06 price, so even the professionals disagree by 24% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
Zurn Elkay Water Solutions (NYSE: ZWS) designs and manufactures water safety, control, flow, hygienic, and filtered drinking water products used in commercial, institutional, municipal, healthcare, and industrial buildings. The company was formed by the 2022 combination of Zurn Water Solutions and Elkay Manufacturing, and it sells under brands including Zurn, Elkay, Wilkins, Halsey Taylor, World Dryer, and Green Turtle. Its portfolio spans drinking fountains and bottle fillers, backflow preventers, trench and roof drains, faucets, and sensor-based hygiene products, giving it broad exposure to the plumbing content inside nonresidential structures. The investment picture centers on a focused, higher-margin water pure-play that has delivered steady core growth and expanding profitability since the merger. ZWS carries a light net debt load, generates recurring free cash flow, and returns cash through buybacks and a dividend. The trade-off is valuation: the stock trades at a premium earnings multiple that already reflects strong execution, so results depend on continued margin gains, synergy capture, and a healthy nonresidential construction backdrop. The 2026 numbers have kept that record intact. First-quarter revenue was about $433 million, up about 11%, and second-quarter revenue was about $491 million, up about 10.5%, with adjusted EPS of $0.41 and $0.50, both ahead of consensus ($0.36 and $0.47); ZWS has now beaten EPS estimates in at least four straight quarters. Trailing revenue reached about $1.79 billion. The stock has not followed: as of October 16, 2026 it was down about 0.5% year to date and up only about 1.6% over one year, trading between roughly $43 and $55 over the prior 52 weeks, and RBC trimmed its target to $54 from $58 in October. Third-quarter results are scheduled for October 27, 2026, with consensus revenue near $493 million and EPS near $0.50. Walnut is not an investment adviser, and this is descriptive context rather than a recommendation.
The bull case: what would have to be true for $65.00
The most optimistic published target on ZWS is $65.00, +38.1% from the $47.06 price as of October 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Water-focused secular demand
ZWS is levered to long-run themes in water quality, safety, conservation, and hygiene across institutional and commercial buildings. Regulatory drivers such as lead-free drinking water mandates and rising focus on building water systems support replacement and upgrade cycles. This gives the top line a structural tailwind beyond the general construction cycle.
2. Margin expansion and synergies
Adjusted EBITDA margins have pushed toward the high-20s percent range, with recent quarters showing continued expansion of over 150 basis points year over year. The company continues to realize cost synergies from the Elkay integration and to run a disciplined operating model. Further mix and productivity gains are the main lever for earnings growth. The trailing GAAP operating margin was about 31% as of mid-2026, and analysts expect 2026 EPS to grow about 21% to roughly $1.83, then about 11% in 2027.
3. Strong cash generation and capital return
ZWS produces consistent free cash flow (about $323 million over the trailing twelve months) and operates with low leverage, holding about $365 million of cash against about $551 million of debt at mid-2026. That balance sheet flexibility funds share repurchases, a dividend (an annual rate of about $0.44 per share), and bolt-on acquisitions in the fragmented water products space. Buybacks have been a steady contributor to per-share results.
4. Nonresidential end-market exposure
The bulk of demand comes from institutional and commercial construction and renovation, including education, healthcare, and public infrastructure. These markets tend to be more stable than residential, but they are still cyclical and sensitive to interest rates and public budgets. Backlog and quoting activity are watched as leading indicators.
The bear case: what would have to be true for $51.00
The most pessimistic published target is $51.00, +8.4% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Zurn Elkay Water Solutions is worth if the risks below bite instead of the drivers above.
ZWS trades at a premium price-to-earnings multiple (about 29x trailing and 23x forward as of October 2026), so any slowdown in growth or margin momentum could pressure the stock; consensus expects growth to slow to about 11% in 2027. Its results are tied to nonresidential construction and renovation activity, which is cyclical and exposed to interest rates, municipal budgets, and commercial real estate weakness. Input costs for metals and components, tariffs, and supply chain disruptions can compress margins. The business is concentrated in North America, and integration or acquisition missteps could weigh on returns. Competition from larger and specialized water and plumbing manufacturers is persistent. Peers are consolidating as well: Pentair expanded its water solutions segment by acquiring Taco in October 2026.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding ZWS already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on ZWS
9 analysts cover ZWS, with an average target of $57.56 (+22.3% against $47.06) and a split of 4 buy, 6 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the ZWS forecast and price target page.
How is ZWS valued? (as of October 2026)
Snapshot for ZWS as of October 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$1.79B
- Q2 2026 revenue: ~$491M (+10.5% YoY)
- Adjusted EPS (Q2 2026): ~$0.50 vs ~$0.47 est.
- Operating margin (TTM): ~31%
- Net income (TTM): ~$273M
- P/E ratio (trailing / forward): ~29x / ~23x
- Dividend yield: ~0.9%
- Market cap: ~$7.7B
As of October 16, 2026, ZWS traded near $46.60, at about 29 times trailing and 23 times forward earnings, down from the high-30s multiple it carried earlier in 2026 because earnings grew while the share price stayed flat. Revenue grew about 10.5% in Q2 2026 and the company keeps generating steady free cash flow with modest leverage. The multiple is still a premium to the broad market, and the nine covering analysts have a mean target near $57.60.
How do you decide if ZWS is a buy?
Rather than asking whether ZWS is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold ZWS indirectly through an index or sector ETF before adding more.
What would change your mind on ZWS
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Water-focused secular demand stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: zWS trades at a premium price-to-earnings multiple (about 29x trailing and 23x forward as of October 2026), so any slowdown in growth or margin momentum could pressure the stock; consensus expects growth to slow to about 11% in 2027 fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the ZWS stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about ZWS against your real portfolio and see your actual exposure before deciding.
Investing in Zurn Elkay Water Solutions with AI
Connect the broker you already use and ask Walnut's AI how ZWS fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is ZWS a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Water-focused secular demand, with revenue (ttm) at ~$1.79B. The bear case rests on zWS trades at a premium price-to-earnings multiple (about 29x trailing and 23x forward as of October 2026), so any slowdown in growth or margin momentum could pressure the stock; consensus expects growth to slow to about 11% in 2027. Analysts covering it are spread from $51.00 to $65.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell ZWS?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. ZWS trades at a premium price-to-earnings multiple (about 29x trailing and 23x forward as of October 2026), so any slowdown in growth or margin momentum could pressure the stock; consensus expects growth to slow to about 11% in 2027. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $51.00, +8.4% from the $47.06 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for ZWS?
+
Water-focused secular demand. ZWS is levered to long-run themes in water quality, safety, conservation, and hygiene across institutional and commercial buildings. The most optimistic analyst target on ZWS is $65.00, +38.1% from the $47.06 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for ZWS?
+
ZWS trades at a premium price-to-earnings multiple (about 29x trailing and 23x forward as of October 2026), so any slowdown in growth or margin momentum could pressure the stock; consensus expects growth to slow to about 11% in 2027. Its results are tied to nonresidential construction and renovation activity, which is cyclical and exposed to interest rates, municipal budgets, and commercial real estate weakness. Input costs for metals and components, tariffs, and supply chain disruptions can compress margins. The business is concentrated in North America, and integration or acquisition missteps could weigh on returns. Competition from larger and specialized water and plumbing manufacturers is persistent. Peers are consolidating as well: Pentair expanded its water solutions segment by acquiring Taco in October 2026. The most pessimistic published target is $51.00, +8.4% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does Zurn Elkay Water Solutions do?
+
Zurn Elkay Water Solutions (NYSE: ZWS) designs and manufactures water safety, control, flow, hygienic, and filtered drinking water products used in commercial, institutional, munic
What would have to change for ZWS to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Water-focused secular demand) stalling in the reported numbers rather than in the narrative, the risk above (zWS trades at a premium price-to-earnings multiple (about 29x trailing and 23x forward as of October 2026), so any slowdown in growth or margin momentum could pressure the stock; consensus expects growth to slow to about 11% in 2027) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does Zurn Elkay Water Solutions do?
+
It designs and manufactures water management and plumbing products, including drinking water systems, backflow preventers, drainage, faucets, and hygiene products, sold mainly into nonresidential buildings such as schools, hospitals, and commercial spaces.
What is the ZWS ticker and where does it trade?
+
ZWS trades on the New York Stock Exchange. The company is headquartered in Milwaukee, Wisconsin, and was formed by the 2022 combination of Zurn Water Solutions and Elkay Manufacturing.
How big is Zurn Elkay?
+
The company generates roughly $1.79 billion in trailing revenue and carried a market capitalization of about $7.7 billion as of October 16, 2026. It employs around 2,600 people.
Walnut is informational, not investment advice, and gives no verdict on ZWS. Analyst targets referenced here come from a October 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.